Cipla’s Q4FY25 revenue rose 9% year-on-year to ₹6,730 crore, while it reported profit after tax of ₹1,222 crore, up 30% from ...

For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

A pill that mimics the effect of a gastric bypass has been touted as the latest weight loss miracle - and may even be more ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

The popularity of expensive weight-loss medications and other prescription drugs along with higher hospital costs are driving ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

White House officials did not say which drugs will be subject to price cuts under the policy, but said Americans could expect ...